Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tegileridine with Itraconazole
NCT05928988Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jan 2022
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tegileridine in postoperative pain and acute pain, sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration at Day 9, Area Under the Curve to Last Quantifiable Concentration at Day 9 and 4 more. Started Jan 2022; status: completed.
02
Drugs
tegileridine
03
Conditions
postoperative painacute pain
Beyond the preview
Go deeper on NCT05928988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05928988.